ghk-cu peptide pill GHK‑Cu Copper Therapy GHK-CU Peptide Compound | 120mcg

By eliminating senescent cells in preclinical systems, FOXO4-DRI indirectly reduces the source of SASP factors

The peptide thus occupies a dual role: it supports broad vitality markers like sleep and immune balance while showing specific reproductive benefits in some reports

The ones who see the most consistent results are the ones who treat the injection protocol as part of the treatment, not an afterthought to it

This targeted approach helps to reduce the harmful effects of cellular senescence, such as tissue dysfunction and inflammation (2)

According to the National Institutes of Health (NIH), the human copper-binding peptide GHK-Cu (glycyl-l-histidyl-l-lysine) is a small, naturally occurring tri-peptide present in human plasma that also can be released from tissues in case of an injury

The healing phase requires specific care that may not include copper peptides